BioNTech SE Announces 2025 Annual General Meeting Date
Ticker: BNTX · Form: 6-K · Filed: 2025-04-04T00:00:00.000Z
Sentiment: neutral
Topics: agm, shareholder-meeting, filing
TL;DR
BioNTech's AGM is set for May 16, 2025. Shareholders, get ready to vote.
AI Summary
BioNTech SE announced on April 4, 2025, that its Annual General Meeting (AGM) for 2025 will be held on May 16, 2025. The company published the invitation to this meeting, which is a standard procedural filing for publicly traded companies.
Why It Matters
The AGM is a crucial event where shareholders can vote on company matters and influence its direction, impacting investor confidence and future strategy.
Risk Assessment
Risk Level: low — This filing is a routine announcement of an upcoming shareholder meeting and does not contain new financial or operational information that would typically pose a risk.
Key Players & Entities
- BioNTech SE (company) — Registrant
- April 4, 2025 (date) — Filing Date
- May 16, 2025 (date) — Annual General Meeting Date
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report the invitation to BioNTech SE's Annual General Meeting 2025.
When will BioNTech SE's Annual General Meeting 2025 be held?
The Annual General Meeting 2025 will be held on May 16, 2025.
Who is the registrant filing this document?
The registrant filing this document is BioNTech SE.
What is the filing date of this report?
This report was filed as of April 4, 2025.
Is BioNTech SE required to file annual reports on Form 20-F or 40-F?
Yes, BioNTech SE indicates it files annual reports under cover of Form 20-F.
From the Filing
0001776985-25-000019.txt : 20250404 0001776985-25-000019.hdr.sgml : 20250404 20250404160907 ACCESSION NUMBER: 0001776985-25-000019 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20250404 FILED AS OF DATE: 20250404 DATE AS OF CHANGE: 20250404 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioNTech SE CENTRAL INDEX KEY: 0001776985 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: 2M FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39081 FILM NUMBER: 25814628 BUSINESS ADDRESS: STREET 1: AN DER GOLDGRUBE 12 CITY: MAINZ STATE: 2M ZIP: 55131 BUSINESS PHONE: 0049613190840 MAIL ADDRESS: STREET 1: AN DER GOLDGRUBE 12 CITY: MAINZ STATE: 2M ZIP: 55131 6-K 1 form6-kagm2025invitation4a.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a‑16 OR 15d‑16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF APRIL 2025 COMMISSION FILE NUMBER 001-39081 BioNTech SE (Translation of registrant’s name into English) An der Goldgrube 12 D-55131 Mainz Germany +49 6131-9084-0 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20‑F or Form 40‑F: Form 20‑F ☒ Form 40‑F ☐ Indicate by check mark if the registrant is submitting the Form 6‑K in paper as permitted by Regulation S‑T Rule 101(b)(1): ☐ Indicate by check mark if the registrant is submitting the Form 6‑K in paper as permitted by Regulation S‑T Rule 101(b)(7): ☐ DOCUMENTS INCLUDED AS PART OF THIS FORM 6-K On April 4, 2025, BioNTech SE (the “Company”) published the invitation to the Annual General Meeting 2025 to be held on May 16, 2025. The invitation and agenda are attached hereto as Exhibit 99.1. SIGNATURE Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BioNTech SE By: /s/ Jens Holstein By: /s/ Dr. Sierk Poetting Name: Jens Holstein Name: Dr. Sierk Poetting Title: Chief Financial Officer Title: Chief Operating Officer Date: April 4, 2025 EXHIBIT INDEX Exhibit Description of Exhibit 99.1 Invitation to the Annual General Meeting 2025 on May 16, 2025 EX-99.1 2 ex991invitationtothe2025an.htm EX-99.1 Document Exhibit 99.1 English Convenience Translation – the German language version is decisive BioNTech SE Mainz WKN A0V9BC | ISIN DE000A0V9BC4 WKN: A2PSR2 | ISIN: US09075V1026 Invitation to the Annual General Meeting 2025 Unique identifier of the event: 6b7baf20e5eaef11b53e00505696f23c Ladies and Gentlemen, We hereby invite our shareholders 1 to the Annual General Meeting of BioNTech SE , Mainz, (the “ Company ”) on Friday, May 16, 2025, at 2:00 p.m. (CEST) 2 The Annual General Meeting will be held as a virtual Annual General Meeting without the physical presence of shareholders or their proxies (with the exception of the Company's proxies). Shareholders who are entered in the Company's share register and have duly registered for the Annual General Meeting, and their proxies, can register for the virtual Annual General Meeting on Friday, May 16, 2025 , via the website available at https://investors.biontech.de/agm/agm-2025 The shareholders can connect to the Annual General Meeting electronically via the password-protected Investor Portal (" Investor Portal ") and participate in the Annual General Meeting in this manner. The physical presence of shareholders and their proxies at the venue of the Annual General Meeting is excluded. Shareholders or their proxies may only exercise their voti